FABRIS, Martina
 Distribuzione geografica
Continente #
NA - Nord America 8.713
AS - Asia 4.130
EU - Europa 2.859
SA - Sud America 763
AF - Africa 84
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.563
Nazione #
US - Stati Uniti d'America 8.564
SG - Singapore 2.023
CN - Cina 828
UA - Ucraina 624
BR - Brasile 618
IT - Italia 602
HK - Hong Kong 451
DE - Germania 441
VN - Vietnam 325
RU - Federazione Russa 274
FI - Finlandia 209
IE - Irlanda 156
GB - Regno Unito 140
IN - India 128
SE - Svezia 114
TR - Turchia 92
CA - Canada 76
FR - Francia 76
KR - Corea 54
MX - Messico 47
AR - Argentina 46
AT - Austria 41
BD - Bangladesh 41
ES - Italia 34
JP - Giappone 33
ZA - Sudafrica 31
ID - Indonesia 29
EC - Ecuador 28
NL - Olanda 27
PL - Polonia 27
BE - Belgio 25
IR - Iran 22
IQ - Iraq 20
PY - Paraguay 19
CO - Colombia 15
CL - Cile 11
EG - Egitto 11
TG - Togo 11
MA - Marocco 10
AU - Australia 9
JM - Giamaica 8
LT - Lituania 8
PE - Perù 8
PK - Pakistan 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
BY - Bielorussia 7
RO - Romania 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
CH - Svizzera 5
IL - Israele 5
KZ - Kazakistan 5
MY - Malesia 5
TN - Tunisia 5
UY - Uruguay 5
VE - Venezuela 5
EE - Estonia 4
EU - Europa 4
HU - Ungheria 4
KG - Kirghizistan 4
NP - Nepal 4
SA - Arabia Saudita 4
TH - Thailandia 4
AL - Albania 3
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
KH - Cambogia 2
LV - Lettonia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
GF - Guiana Francese 1
GH - Ghana 1
GM - Gambi 1
GR - Grecia 1
IM - Isola di Man 1
KW - Kuwait 1
Totale 16.552
Città #
Woodbridge 1.008
Singapore 814
Ann Arbor 768
Ashburn 666
Chandler 657
Fairfield 654
Houston 530
Beijing 470
Hong Kong 444
Jacksonville 435
Wilmington 315
Dearborn 287
Seattle 265
Boardman 202
Cambridge 200
Udine 161
Dublin 150
Princeton 145
Los Angeles 133
Dallas 112
Ho Chi Minh City 95
Munich 79
Izmir 77
Dong Ket 70
Redondo Beach 64
Hefei 62
San Diego 59
Hanoi 58
Buffalo 57
São Paulo 57
Redmond 56
New York 54
Trieste 53
Seoul 48
Norwalk 36
Ogden 36
Venezia 35
Santa Clara 32
Montreal 30
Nuremberg 28
Tokyo 28
The Dalles 27
Des Moines 26
Milan 26
Nanjing 26
Guangzhou 25
Brussels 24
Warsaw 24
Belluno 23
Denver 23
Mumbai 23
Ottawa 23
Düsseldorf 22
San Mateo 21
Johannesburg 20
Orem 20
Phoenix 20
Rio de Janeiro 20
Chennai 19
Mexico City 19
Stockholm 19
Frankfurt am Main 18
London 18
Leawood 17
Poplar 16
Vienna 16
Amsterdam 15
Boston 15
Augusta 14
Chicago 14
Helsinki 14
Kunming 14
Belo Horizonte 13
Council Bluffs 13
Grafing 13
Lappeenranta 13
Lauterbourg 13
Querétaro 13
Toronto 13
Turku 13
Brooklyn 12
Rome 12
Codroipo 11
Da Nang 11
Lomé 11
San Francisco 11
Tavagnacco 11
Ribeirão Preto 10
Salvador 10
Baghdad 9
Hyderabad 9
Miami 9
Ansbach 8
Atlanta 8
Auburn Hills 8
Biên Hòa 8
Brasília 8
Curitiba 8
Guayaquil 8
Monmouth Junction 8
Totale 10.445
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 260
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 240
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 219
Twist is substrate for caspase cleavage and proteasome-mediated degradation 198
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 193
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 188
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 181
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 176
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 176
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 168
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 166
Cardiovascular Complications of Acromegaly. 165
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 161
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 160
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 151
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 149
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 146
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 144
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 143
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 142
BLyS and April serum levels in patients with autoimmune thyroid diseases. 141
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 141
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 140
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 136
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 135
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 134
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 133
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 133
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 133
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 132
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 132
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 130
Epidemiology of paraneoplastic neurological syndromes: a population-based study 129
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 128
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 127
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 124
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 121
B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Disease Behavior 116
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 115
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 114
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 113
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 113
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 113
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 112
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 112
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 112
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 112
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 112
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 112
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 110
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 108
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 108
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 107
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 107
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 107
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 107
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 107
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 106
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up. 105
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 105
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 105
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 105
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 104
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 101
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 101
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 101
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 100
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 100
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 99
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 99
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 98
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 98
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 97
Italy association of transforming growth factor-b (tgf-b) 869cc polymorphism with bone erosions in rheumatoid arthritis: an ultrasonographic study. 96
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) 96
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 96
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 95
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 95
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 95
B-Lymphocyte Stimulator in neuroendocrine tumors: correlation with disease behaviour. 95
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 95
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 94
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 94
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 94
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn) 93
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation 92
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study 92
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 91
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 91
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 91
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 91
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. 90
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 90
Chlamydophila psittaci subclinical infection in chronic polyarthritis 89
Improving the diagnostic approach to type I diabetes: the introduction of anti-zinc transporter protein autoantibodies (ZnT8A)(835.15) 89
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 88
An Italilan multicenter controlled study of HCV-related malignancies: role of the HLA class II. 88
B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection 88
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 88
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 87
Totale 12.099
Categoria #
all - tutte 68.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.094 0 0 0 0 0 173 74 161 283 54 232 117
2021/20221.147 62 122 35 94 51 29 44 62 13 176 280 179
2022/20231.542 167 116 9 234 126 382 23 136 206 18 65 60
2023/2024499 73 37 24 15 75 62 13 54 58 46 12 30
2024/20253.244 83 213 228 136 118 142 233 196 354 276 495 770
2025/20263.754 531 572 510 780 860 501 0 0 0 0 0 0
Totale 16.936